2020 EAU指南:肾细胞癌(更新版)

2020-03-26 EAU官网

2020年3月,欧洲泌尿外科学会(EAU)更新发布了肾细胞癌指南,指南主要目的是为肾癌(RCC)的临床管理提供实践指导,内容涉及肾细胞癌的管理,包括诊断分期,分类和预后因素,其他肾脏肿瘤,局部肾肿瘤的

中文标题:

2020 EAU指南:肾细胞癌(更新版)

英文标题:

EAU Guidelines on Renal Cell Carcinoma

发布机构:

发布日期:

2020-03-26

简要介绍:

2020年3月,欧洲泌尿外科学会(EAU)更新发布了肾细胞癌指南,指南主要目的是为肾癌(RCC)的临床管理提供实践指导,内容涉及肾细胞癌的管理,包括诊断分期,分类和预后因素,其他肾脏肿瘤,局部肾肿瘤的治疗,转移性肾肿瘤的系统治疗,监测随访。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (23)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1190621, encodeId=f0f6119062152, content=写毕业论文啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe086471140, createdName=ms9000001252511009, createdTime=Sun Feb 06 23:32:11 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055968, encodeId=399f1055968dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e95495433, createdName=ttyydedie, createdTime=Wed Sep 29 09:54:21 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996508, encodeId=c4d4996508c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/53d45c2569b14848bbdceec7ae77f740/461622f7642c4f33a14ad12a1fc81ff0.jpg, createdBy=c8ef5439557, createdName=维萨里, createdTime=Mon Jul 05 20:07:46 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978191, encodeId=56719e8191cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec235476032, createdName=ms1000001439107490, createdTime=Wed Jun 30 13:12:30 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972692, encodeId=08779e2692a3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3992031387, createdName=2415, createdTime=Thu Jun 10 23:12:30 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2022-02-06 ms9000001252511009

    写毕业论文啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1190621, encodeId=f0f6119062152, content=写毕业论文啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe086471140, createdName=ms9000001252511009, createdTime=Sun Feb 06 23:32:11 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055968, encodeId=399f1055968dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e95495433, createdName=ttyydedie, createdTime=Wed Sep 29 09:54:21 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996508, encodeId=c4d4996508c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/53d45c2569b14848bbdceec7ae77f740/461622f7642c4f33a14ad12a1fc81ff0.jpg, createdBy=c8ef5439557, createdName=维萨里, createdTime=Mon Jul 05 20:07:46 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978191, encodeId=56719e8191cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec235476032, createdName=ms1000001439107490, createdTime=Wed Jun 30 13:12:30 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972692, encodeId=08779e2692a3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3992031387, createdName=2415, createdTime=Thu Jun 10 23:12:30 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-09-29 ttyydedie

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1190621, encodeId=f0f6119062152, content=写毕业论文啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe086471140, createdName=ms9000001252511009, createdTime=Sun Feb 06 23:32:11 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055968, encodeId=399f1055968dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e95495433, createdName=ttyydedie, createdTime=Wed Sep 29 09:54:21 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996508, encodeId=c4d4996508c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/53d45c2569b14848bbdceec7ae77f740/461622f7642c4f33a14ad12a1fc81ff0.jpg, createdBy=c8ef5439557, createdName=维萨里, createdTime=Mon Jul 05 20:07:46 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978191, encodeId=56719e8191cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec235476032, createdName=ms1000001439107490, createdTime=Wed Jun 30 13:12:30 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972692, encodeId=08779e2692a3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3992031387, createdName=2415, createdTime=Thu Jun 10 23:12:30 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-07-05 维萨里

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1190621, encodeId=f0f6119062152, content=写毕业论文啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe086471140, createdName=ms9000001252511009, createdTime=Sun Feb 06 23:32:11 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055968, encodeId=399f1055968dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e95495433, createdName=ttyydedie, createdTime=Wed Sep 29 09:54:21 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996508, encodeId=c4d4996508c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/53d45c2569b14848bbdceec7ae77f740/461622f7642c4f33a14ad12a1fc81ff0.jpg, createdBy=c8ef5439557, createdName=维萨里, createdTime=Mon Jul 05 20:07:46 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978191, encodeId=56719e8191cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec235476032, createdName=ms1000001439107490, createdTime=Wed Jun 30 13:12:30 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972692, encodeId=08779e2692a3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3992031387, createdName=2415, createdTime=Thu Jun 10 23:12:30 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-30 ms1000001439107490

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1190621, encodeId=f0f6119062152, content=写毕业论文啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe086471140, createdName=ms9000001252511009, createdTime=Sun Feb 06 23:32:11 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055968, encodeId=399f1055968dc, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7e95495433, createdName=ttyydedie, createdTime=Wed Sep 29 09:54:21 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996508, encodeId=c4d4996508c8, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210705/53d45c2569b14848bbdceec7ae77f740/461622f7642c4f33a14ad12a1fc81ff0.jpg, createdBy=c8ef5439557, createdName=维萨里, createdTime=Mon Jul 05 20:07:46 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978191, encodeId=56719e8191cd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec235476032, createdName=ms1000001439107490, createdTime=Wed Jun 30 13:12:30 CST 2021, time=2021-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972692, encodeId=08779e2692a3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a3992031387, createdName=2415, createdTime=Thu Jun 10 23:12:30 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-10 2415

    学习了

    0

拓展阅读

2014 ESMO临床实践指南:肾细胞癌的诊治及随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2014-09-16

2014 EAU指南:肾细胞癌(更新版)

欧洲泌尿外科学会(EAU,European Association of Urology) · 2015-01-20

2016 ESMO临床实践指南:肾细胞癌的诊断,治疗及随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2016-09-20

2019 ESMO临床实践指南:肾细胞癌的诊断,治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2019-02-21

2019 EAU指南:肾细胞癌(更新版)

欧洲泌尿外科学会(EAU,European Association of Urology) · 2019-02-22

2019 SITC共识声明:晚期肾细胞癌(RCC)免疫治疗

肿瘤免疫治疗学会(SITC,Society for Immunotherapy of Cancer) · 2019-12-20